VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIVS VivoSim Lab, Inc.

交易中 04-13 10:06:03 EDT

1.44

-0.01

-0.69%

最高1.44	最低1.44	成交量1,414
今开1.44	昨收1.45	日振幅0.00%
总市值416.81万	流通市值412.96万	总股本289.45万
成交额2,049	换手率0.05%	流通股本286.78万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIVS","market":"US","secType":"STK","nameCN":"VivoSim Lab, Inc.","latestPrice":1.44,"timestamp":1776089076834,"preClose":1.45,"halted":0,"volume":1414,"delay":0,"changeRate":-0.006896551724137937,"floatShares":2867799,"shares":2894500,"eps":-0.525304,"marketStatus":"交易中","change":-0.01,"latestTime":"04-13 10:06:03 EDT","open":1.44,"high":1.44,"low":1.44,"amount":2048.9967162000003,"amplitude":0,"askPrice":1.48,"askSize":340,"bidPrice":1.45,"bidSize":201,"shortable":3,"etf":0,"ttmEps":-0.525304,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776110400000},"marketStatusCode":2,"adr":0,"listingDate":1373515200000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.48,"preClose":1.45,"latestTime":"08:27 EDT","volume":280,"amount":414.361808,"timestamp":1776083265051,"change":0.03,"changeRate":0.02069,"amplitude":0.004621},"postHourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.45,"latestTime":"18:36 EDT","volume":489,"amount":745.63,"timestamp":1775860600593,"change":0.08,"changeRate":0.055172,"amplitude":0.055172},"volumeRatio":0.284057},"requestUrl":"/m/hq/s/VIVS/wiki","defaultTab":"wiki","newsList":[{"id":"2614049751","title":"Vivosim Labs, Inc.盘中异动 急速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614049751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614049751?lang=zh_cn&edition=full","pubTime":"2026-02-26 04:11","pubTimestamp":1772050297,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日04时11分，Vivosim Labs, Inc.股票出现异动，股价快速上涨5.41%。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病，包括溃疡性结肠炎，基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226041137a4c85b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134671302","title":"VivoSim Lab, Inc. 通过韩国和中国新分销协议扩大Namkind™人源毒理学服务在亚太地区的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1134671302","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134671302?lang=zh_cn&edition=full","pubTime":"2026-01-30 05:08","pubTimestamp":1769720903,"startTime":"0","endTime":"0","summary":"VivoSim Lab, Inc. 近日宣布，公司已签署新的分销协议，旨在将旗下Namkind™人源毒理学服务更广泛地引入韩国和中国市场。此举标志着该公司在拓展亚太地区业务版图方面迈出了关键一步，旨在满足该区域日益增长的对先进、可靠毒理学测试方案的需求。\n通过此项战略合作，VivoSim Lab, Inc. 将借助当地分销伙伴的网络与专业优势，提升其创新服务的覆盖范围与市场渗透力。Namkind™技术平台以其基于人类生物学的独特测试模型而著称，有望为亚太地区的药物研发、化学品安全评估及相关生命科学领域提供更精准、更具预测性的人体反应数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602122803","title":"Vivosim Labs, Inc.盘中异动 大幅下跌8.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602122803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602122803?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:55","pubTimestamp":1767894943,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日01时55分，Vivosim Labs, Inc.股票出现异动，股价大幅下挫8.35%。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病，包括溃疡性结肠炎，基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBD","VIVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2587075284","title":"Vivosim Labs, Inc.盘中异动 早盘股价大涨7.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587075284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587075284?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:33","pubTimestamp":1764340392,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日22时33分，Vivosim Labs, Inc.股票出现波动，股价大幅上涨7.31%。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病，包括溃疡性结肠炎，基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128223312a4c0a7f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128223312a4c0a7f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBD","VIVS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivosim.ai","stockEarnings":[{"period":"1week","weight":-0.142},{"period":"1month","weight":-0.2526},{"period":"3month","weight":-0.2448},{"period":"6month","weight":-0.523},{"period":"1year","weight":-0.3349},{"period":"ytd","weight":-0.1989}],"compareEarnings":[{"period":"1week","weight":0.036},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.021},{"period":"6month","weight":0.0405},{"period":"1year","weight":0.2952},{"period":"ytd","weight":-0.0036}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VivoSim Labs, Inc.成立于2007年，从事开发和商业化可以应用在药物发现和开发，进行生物学研究，作为植入受损或退化组织和器官的治疗的人体组织技术平台。VivoSim计划引进到三维人体组织，通过构建三维创作，复制天然人类生物学的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.001588},{"month":2,"riseRate":0.538462,"avgChangeRate":0.0713},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.135222},{"month":4,"riseRate":0.538462,"avgChangeRate":-0.006219},{"month":5,"riseRate":0.5,"avgChangeRate":0.055044},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.085299},{"month":7,"riseRate":0.333333,"avgChangeRate":0.012792},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.076461},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.037473},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.055078},{"month":11,"riseRate":0.461538,"avgChangeRate":0.059307},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.024045}],"exchange":"NASDAQ","name":"VivoSim Lab, Inc.","nameEN":"VivoSim Lab, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VivoSim Lab, Inc.,VIVS,VivoSim Lab, Inc.股票,VivoSim Lab, Inc.股票老虎,VivoSim Lab, Inc.股票老虎国际,VivoSim Lab, Inc.行情,VivoSim Lab, Inc.股票行情,VivoSim Lab, Inc.股价,VivoSim Lab, Inc.股市,VivoSim Lab, Inc.股票价格,VivoSim Lab, Inc.股票交易,VivoSim Lab, Inc.股票购买,VivoSim Lab, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VivoSim Lab, Inc.(VIVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VivoSim Lab, Inc.(VIVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}